244
Views
52
CrossRef citations to date
0
Altmetric
Review

CYP2E1-dependent oxidative stress and toxicity: role in ethanol-induced liver injury

&
Pages 671-685 | Published online: 30 Nov 2005

Bibliography

  • GUENGERICH FP: Mammalian cytochrome P450. CRC Press, Boca Raton, FL, USA (1987).
  • NELSON DR, KOYMANS L, KAMATAKI T et al. : P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics (1996) 6(1):1–42.
  • PORTER TD, COON MJ: Cytochrome P450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J. Biol. Chem. (1991) 266(21):13469–13472.
  • GUENGERICH FP: Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. (2001) 14(6):611–650.
  • LEWIS DF, PRATT JM: The P450 catalytic cycle and oxygenation mechanism. Drug Metab. Rev. (1998) 30(4):739–786.
  • GOEPTAR AR, SCHEERENS H, VERMEULEN NP: Oxygen and xenobiotic reductase activities of cytochrome P450. Crit. Rev. Toxicol. (1995) 25(1):25–65.
  • GORSKY LD, KOOP DR, COON MJ: On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P450. Products of oxygen reduction. J. Biol. Chem. (1984) 259(11):6812–6817.
  • EKSTROM G, INGELMAN-SUNDBERG M: Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450 (P450IIE1). Biochem. Pharmacol. (1989) 38(8):1313–1319.
  • WHITE RE: The involvement of free radicals in the mechanisms of monooxygenases. Pharmacol. Ther. (1991) 49(1–2):21–42.
  • LOIDA PJ, SLIGAR SG: Molecular recognition in cytochrome P450: mechanism for the control of uncoupling reactions. Biochemistry (1993) 32(43):11530–11538.
  • KUTHAN H, TSUJI H, GRAF H, ULLRICH V: Generation of superoxide anion as a source of hydrogen peroxide in a reconstituted monooxygenase system. FEBS Lett. (1978) 91(2):343–345.
  • WHITE RE, COON MJ: Oxygen activation by cytochrome P450. Ann. Rev. Biochem. (1980) 49:315–356.
  • ZANGAR RC, DAVYDOV DR, VERMA S: Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. (2004) 199(3):316–331.
  • KNIGHT JA: Free radicals: their history and current status in aging and disease. Ann. Clin. Lab. Sci. (1998) 28(6):331–346.
  • KEHRER JP: Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. (1993) 23(1):21–48.
  • NORDMANN R, RIBIERE C, ROUACH H: Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic. Biol. Med. (1992) 12(3):219–240.
  • HALLIWELL B: Antioxidant defense mechanisms: from the beginning to the end (of the beginning). Free Radic. Res. (1999) 31(4):261–272.
  • YU BP: Cellular defenses against damage from reactive oxygen species. Physiol. Rev. (1994) 74(1):139–162.
  • ROSEN GM, POU S, RAMOS CL, COHEN MS, BRITIGAN BE: Free radicals and phagocytic cells. FASEB J. (1995) 9(2):200–209.
  • LANDER HM: An essential role for free radicals and derived species in signal transduction. FASEB J. (1997) 11(2):118–124.
  • CEDERBAUM AI: Introduction-serial review: alcohol, oxidative stress and cell injury. Free Radic. Biol. Med. (2001) 31(12):1524–1526.
  • MORIMOTO M, ZERN MA, HAGBJORK AL, INGELMAN-SUNDBERG M, FRENCH SW: Fish oil, alcohol and liver pathology: role of cytochrome P450 2E1. Proc. Soc. Exp. Biol. Med. (1994) 207(2):197–205.
  • NANJI AA, ZHAO S, SADRZADEH SM, DANNENBERG AJ, TAHAN SR, WAXMAN DJ: Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats. Alcohol. Clin. Exp. Res. (1994) 18(5):1280–1285.
  • IIMURO Y, BRADFORD BU, YAMASHINA S et al. : The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology (2000) 31(2):391–398.
  • TSUKAMOTO H, HORNE W, KAMIMURA S et al. : Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. (1995) 96(1):620–630.
  • LIEBER CS: Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998) - a review. Alcohol. Clin. Exp. Res. (1999) 23(6):991–1007.
  • LIEBER CS, DECARLI LM: The role of the hepatic microsomal ethanol-oxidizing system (MEOS) for ethanol metabolism in vivo. J. Pharmacol. Exp. Ther. (1972) 181(2):279–287.
  • KOOP DR, MORGAN ET, TARR GE, COON MJ: Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. (1982) 257(14):8472–8480.
  • INGELMAN-SUNDBERG M, JOHANSSON I, PENTTILA KE, GLAUMANN H, LINDROS KO: Centrilobular expression of ethanolinducible cytochrome P450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. (1988) 157(1):55–60.
  • LOEPER J, DESCATOIRE V, MAURICE M et al. : Presence of functional cytochrome P450 on isolated rat hepatocyte plasma membrane. Hepatology (1990) 11(5):850–858.
  • LYTTON SD, HELANDER A, ZHANG-GOUILLON ZQ et al. : Autoantibodies against cytochrome P4502E1 and P4503A in alcoholics. Mol. Pharmacol. (1999) 55(2):223–233.
  • NEVE EP, INGELMAN-SUNDBERG M: Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. J. Biol. Chem. (2000) 275(22):17130–17135.
  • NEVE EP, INGELMAN-SUNDBERG M: A soluble NH2-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria. FEBS Lett. (1999) 460(2):309–314.
  • ROBIN MA, ANANDATHEERTHAVARADA HK, FANG JK, CUDIC M, OTVOS L, AVADHANI NG: Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N terminus and requires mitochondrial specific electron transfer proteins for activity. J. Biol. Chem. (2001) 276(27):24680–24689.
  • KOOP DR, CASAZZA JP: Identification of ethanol-inducible P450 isozyme 3A as the acetone and acetol monooxygenase of rabbit microsomes. J. Biol. Chem. (1985) 260(25):13607–13612.
  • BONDOC FY, BAO Z, HU WY et al. : Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochem. Pharmacol. (1999) 58(3):461–463.
  • LAETHEM RM, BALAZY M, FALCK JR, LAETHEM CL, KOOP DR: Formation of 19(S)-, 19(R)- and 18(R)- hydroxyeicosatetraenoic acids by alcoholinducible cytochrome P450 2E1. J. Biol. Chem. (1993) 268(17):12912–12918.
  • KOOP DR: Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. (1992) 6(2):724–730.
  • RAUCY JL, KRANER JC, LASKER JM: Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. (1993) 23(1):1–20.
  • TANAKA E, TERADA M, MISAWA S: Cytochrome P450 2E1: its clinical and toxicological role. J. Clin. Pharm. Ther. (2000) 25(3):165–175.
  • BOLT HM, ROOS PH, THIER R: The cytochrome P450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int. Arch. Occup. Environ. Health (2003) 76(3):174–185.
  • YANG CS, YOO JS, ISHIZAKI H, HONG JY: Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev. (1990) 22(2–3):147–159.
  • GIRRE C, LUCAS D, HISPARD E, MENEZ C, DALLY S, MENEZ JF: Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. (1994) 47(9):1503–1508.
  • WANG MH, WADE D, CHEN L, WHITE S, YANG CS: Probing the active sites of rat and human cytochrome P450 2E1 with alcohols and carboxylic acids. Arch. Biochem. Biophys. (1995) 317(1):299–304.
  • LEWIS DF, BIRD MG, PARKE DV: Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. Toxicology (1997) 118(2–3):93–113.
  • TAN Y, WHITE SP, PARANAWITHANA SR, YANG CS: A hypothetical model for the active site of human cytochrome P4502E1. Xenobiotica (1997) 27(3):287–299.
  • LEWIS DF, BIRD MG, DICKINS M et al. : Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform. Xenobiotica (2000) 30(1):1–25.
  • LEWIS DF, LAKE BG, BIRD MG, LOIZOU GD, DICKINS M, GOLDFARB PS: Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzymesubstrate and enzyme-inhibitor interactions. Toxicol. In Vitro (2003) 17(1):93–105.
  • SZCZESNA-SKORUPA E, MALLAH B, KEMPER B: Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells. J. Biol. Chem. (2003) 278(33):31269–31276.
  • FUKUDA T, IMAI Y, KOMORI M et al. : Replacement of Thr-303 of P450 2E1 with serine modifies the regioselectivity of its fatty acid hydroxylase activity. J. Biochem. (1993) 113(1):7–12.
  • PORTER TD: Mutagenesis at a highly conserved phenylalanine in cytochrome P450 2E1 affects heme incorporation and catalytic activity. Biochemistry (1994) 33(19):5942–5946.
  • SPATZENEGGER M, LIU H, WANG Q, DEBARBER A, KOOP DR, HALPERT JR: Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. J. Pharmacol. Exp. Ther. (2003) 304(1):477–487.
  • PUNTARULO S, CEDERBAUM AI: Increased NADPH-dependent chemiluminescence by microsomes after chronic ethanol consumption. Arch. Biochem. Biophys. (1988) 266(2):435–445.
  • RASHBA-STEP J, TURRO NJ, CEDERBAUM AI: Increased NADPHand NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch. Biochem. Biophys. (1993) 300(1):401–408.
  • KUKIELKA E, CEDERBAUM AI: DNA strand cleavage as a sensitive assay for the production of hydroxyl radicals by microsomes: role of cytochrome P4502E1 in the increased activity after ethanol treatment. Biochem. J. (1994) 302(3):773–779.
  • WU YS, SALMELA KS, LIEBER CS: Microsomal acetaldehyde oxidation is negligible in the presence of ethanol. Alcohol. Clin. Exp. Res. (1998) 22(5):1165–1169.
  • ALBANO E, TOMASI A, PERSSON JO et al. : Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. (1991) 41(12):1895–1902.
  • KNECHT KT, THURMAN RG, MASON RP: Role of superoxide and trace transition metals in the production of α-hydroxyethyl radical from ethanol by microsomes from alcohol dehydrogenasedeficient deermice. Arch. Biochem. Biochys. (1993) 303(2):339–348.
  • RAO DN, YANG MX, LASKER JM, CEDERBAUM AI: 1-Hydroxyethyl radical formation during NADPH- and NADHdependent oxidation of ethanol by human liver microsomes. Mol. Pharmacol. (1996) 49(5):814–821.
  • REINKE LA, LAI EK, DUBOSE CM, McCAY PB: Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc. Natl. Acad. Sci. USA (1987) 84(24):9223–9227.
  • CLOT P, ALBANO E, ELIASSON E et al. : Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics. Gastroenterology (1996) 111(1):206–216.
  • HARADA S, AGARWAL DP, NOMURA F, HIGUCHI S: Metabolic and ethnic determinants of alcohol drinking habits and vulnerability to alcohol-related disorder. Alcohol. Clin. Exp. Res. (2001) 25(5):71S–75S.
  • ITOGA S, NOMURA F, HARADA S, TSUTSUMI M, TAKASE S, NAKAI T: Mutations in the exons and exon-intron junction regions of human cytochrome P4502E1 gene and alcoholism. Alcohol. Clin. Exp. Res. (1999) 23(4):13S–16S.
  • BADGER TM, RONIS MJ, SEITZ HK, ALBANO E, INGELMAN-SUNDBERG M, LIEBER CS: Alcohol metabolism: role in toxicity and carcinogenesis. Alcohol. Clin. Exp. Res. (2003) 27(2):336–347.
  • SONG BJ, GELBOIN HV, PARK SS, YANG CS, GONZALEZ FJ: Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J. Biol. Chem. (1986) 261(35):16689–16697.
  • SONG BJ, CEDERBAUM AI, KOOP DR, INGELMAN-SUNDBERG M, NANJI A: Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance. Alcohol. Clin. Exp. Res. (1996) 20(Suppl.):138A–146A.
  • RAUCY JL, LASKER JM, KRANER JC, SALAZAR DE, LIEBER CS, CORCORAN GB: Induction of cytochrome P450IIE1 in the obese overfed rat. Mol. Pharmacol. (1991) 39(3):275–280.
  • HONG JY, PAN JM, GONZALEZ FJ, GELBOIN HV, YANG CS: The induction of a specific form of cytochrome P450 (P450j) by fasting. Biochem. Biophys. Res. Commun. (1987) 142(3):1077–1083.
  • WOODCROFT KJ, HAFNER MS, NOVAK RF: Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology (2002) 35(2):263–273.
  • DE WAZIERS I, GARLATTI M, BOUGUET J, BEAUNE PH, BAROUKI R: Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol. Pharmacol. (1995) 47(3):474–479.
  • WOODCROFT KJ, NOVAK RF: Insulin effects on CYP2E1, 2B, 3A and 4A expression in primary cultured rat hepatocytes. Chem. Biol. Interact. (1997) 107(1–2):75–91.
  • BELLWARD GD, CHANG T, RODRIGUES B et al. : Hepatic cytochrome P450j induction in the spontaneously diabetic BB rat. Mol. Pharmacol. (1988) 33(2):140–143.
  • YOO JS, NING SM, PANTUCK CB, PANTUCK EJ, YANG CS: Regulation of hepatic microsomal cytochrome P450IIE1 level by dietary lipids and carbohydrates in rats. J. Nutr. (1991) 121(7):959–965.
  • LINDROS KO, JARVELAINEN HA: A new oral low-carbohydrate alcohol liquid diet producing liver lesions: a preliminary account. Alcohol Alcohol. (1998) 33(4):347–353.
  • HONG JY, NING SM, MA BL, LEE MJ, PAN JM, YANG CS: Roles of pituitary hormones in the regulation of hepatic cytochrome P450IIE1 in rats and mice. Arch. Biochem. Biophys. (1990) 281(1):132–138.
  • ELIASSON E, MKRTCHIAN S, INGELMAN-SUNDBERG M: Hormone- and substrate-regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J. Biol. Chem. (1992) 267(22):15765–15769.
  • HOIVIK DJ, MANAUTOU JE, TVEIT A, HART SG, KHAIRALLAH EA, COHEN SD: Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity in the CD-1 mouse. Toxicol. Appl. Pharmacol. (1995) 130(2):257–271.
  • WELTMAN MD, FARRELL GC, HALL P, INGELMAN-SUNDBERG M, LIDDLE C: Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (1998) 27(1):128–133.
  • LECLERCQ IA, FARRELL GC, FIELD J, BELL DR, GONZALEZ FJ, ROBERTSON GR: CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. (2000) 105(8):1067–1075.
  • ROBERTSON G, LECLERCQ I, FARRELL GC: Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. (2001) 281(5):G1135–G1139.
  • KOOP DR, TIERNEY DJ: Multiple mechanisms in the regulation of ethanolinducible cytochrome P450IIE1. Bioessays (1990) 12(9):429–435.
  • SONG BJ, MATSUNAGA T, HARDWICK JP et al. : Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol. Endocrinol. (1987) 1(8):542–547.
  • SONG BJ, VEECH RL, PARK SS, GELBOIN HV, GONZALEZ FJ: Induction of rat hepatic Nnitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. (1989) 264(6):3568–3572.
  • ELIASSON E, JOHANSSON I, INGELMAN-SUNDBERG M: Liganddependent maintenance of ethanolinducible cytochrome P450 in primary rat hepatocyte cell cultures. Biochem. Biophys. Res. Commun. (1988) 150(1):436–443.
  • WU DF, CLEJAN L, POTTER B, CEDERBAUM AI: Rapid decrease of cytochrome P450IIE1 in primary hepatocyte culture and its maintenance by added 4-methylpyrazole. Hepatology (1990) 12(6):1379–1389.
  • RONIS MJ, HUANG J, CROUCH J et al. : Cytochrome P450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentrations in rats. J. Pharmacol. Exp. Ther. (1993) 264(2):944–950.
  • MCGEHEE RE Jr, RONIS MJ, COWHERD RM, INGELMAN-SUNDBERG M, BADGER TM: Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol. Biochem. Pharmacol. (1994) 48(9):1823–1833.
  • ROBERTS BJ, SHOAF SE, JEONG KS, SONG BJ: Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem. Biophys. Res. Commun. (1994) 205(2):1064–1071.
  • ROBERTS BJ, SONG BJ, SOH Y, PARK SS, SHOAF SE: Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J. Biol. Chem. (1995) 270(50):29632–29635.
  • WINTERS DK, CEDERBAUM AI: Time course characterization of the induction of cytochrome P450 2E1 by pyrazole and 4-methylpyrazole. Biochim. Biophys. Acta (1992) 1117(1):15–24.
  • WU D, CEDERBAUM AI: Induction of liver cytochrome P4502E1 by pyrazole and 4-methylpyrazole in neonatal rats. J. Pharmacol. Exp. Ther. (1993) 264(3):1468–1473.
  • YANG MX, CEDERBAUM AI: Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1. Arch. Biochem. Biophys. (1997) 341(1):25–33.
  • ROBERTS BJ: Evidence of proteasomemediated cytochrome P450 degradation. J. Biol. Chem. (1997) 272(15):9771–9778.
  • BARDAG-GORCE F, LI J, FRENCH BA, FRENCH SW: Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341. Free Radic. Biol. Med. (2002) 32(1):17–21.
  • LEE SS, BUTERS JT, PINEAU T, FERNANDEZ-SALGUERO P, GONZALEZ FJ: Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. (1996) 271(20):12063–12067.
  • WANG H, CHANAS B, GHANAYEM BI: Cytochrome P450 2E1 (CYP2E1) is essential for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice. Drug Metab. Dispos. (2002) 30(8):911–917.
  • CARLSON GP: Comparison of the susceptibility of wild-type and CYP2E1- knockout mice to the hepatotoxic and pneumotoxic effects of styrene and styrene oxide. Toxicol. Lett. (2004) 150(3):335–339.
  • WOLF KK, WOOD SG, BEMENT JL et al. : Role of mouse CYP2E1 in the Ohydroxylation of p-nitrophenol: comparison of activities in hepatic microsomes from CYP2E1(-/-) and wild-type mice. Drug Metab. Dispos. (2004) 32(7):681–684.
  • KONO H, BRADFORD BU, YIN M et al. : CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol. (1999) 277(6):G1259–G1267.
  • BARDAG-GORCE F, YUAN QX, LI J et al. : The effect of ethanol-induced cytochrome P4502E1 on the inhibition of proteasome activity by alcohol. Biochem. Biophys. Res. Commun. (2000) 279(1):23–29.
  • CHEUNG C, YU AM, WARD JM et al. : The CYP2E1-humanized transgenic mouse: role of CYP2E1 in acetaminophen hepatotoxicity. Drug Metab. Dispos. (2005) 33(3):449–457.
  • MORIMOTO M, HAGBJORK AL, WAN YJ et al. : Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology (1995) 21(6):1610–1617.
  • CASTILLO T, KOOP DR, KAMIMURA S, TRIADAFILOPOULOS G, TSUKAMOTO H: Role of cytochrome P450 2E1 in ethanol-, carbon tetrachloride and iron-dependent microsomal lipid peroxidation. Hepatology (1992) 16(4):992–996.
  • FRENCH SW, MORIMOTO M, REITZ RC et al. : Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats. J. Nutr. (1997) 127(5):907S–911S.
  • GOUILLON Z, LUCAS D, LI J et al. : Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc. Soc. Exp. Biol. Med. (2000) 224(4):302–308.
  • LIEBER CS, LEO MA, ALEYNIK SI, ALEYNIK MK, DECARLI LM: Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol. Clin. Exp. Res. (1997) 21(2):375–379.
  • MORGAN K, FRENCH SW, MORGAN TR: Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology (2002) 36(1):122–134.
  • WHEELER MD, KONO H, YIN M et al. : The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic. Biol. Med. (2001) 31(12):1544–1549.
  • YIN M, WHEELER MD, KONO H et al. : Essential role of tumor necrosis factor-α in alcohol-induced liver injury in mice. Gastroenterology (1999) 117(4):942–952.
  • KOOP DR, KLOPFENSTEIN B, IIMURO Y, THURMAN RG: Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol. Pharmacol. (1997) 51(6):944–950.
  • BADGER DA, KUESTER RK, SAUER JM, SIPES IG: Gadolinium chloride reduces cytochrome P450: relevance to chemical-induced hepatotoxicity. Toxicology (1997) 121(2):143–153.
  • JARVELAINEN HA, FANG C, INGELMAN-SUNDBERG M, LUKKARI TA, SIPPEL H, LINDROS KO: Kupffer cell inactivation alleviates ethanolinduced steatosis and CYP2E1 induction, but not inflammatory responses in rat liver. J. Hepatol. (2000) 32(6):900–910.
  • TSUKAMOTO H: CYP2E1 and ALD. Hepatology (2000) 32(1):154–156.
  • BRADFORD BU, KONO H, ISAYAMA F et al. : Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanolinduced oxidative DNA damage in rodent liver. Hepatology (2005) 41(2):336–344.
  • DAI Y, RASHBA-STEP J, CEDERBAUM AI: Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry (1993) 32(27):6928–6937.
  • CHEN Q, CEDERBAUM AI: Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in HepG2 cells. Mol. Pharmacol. (1998) 53(4):638–648.
  • DAI Y, CEDERBAUM AI: Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J. Pharmacol. Exp. Ther. (1995) 273(3):1497–1505.
  • DAI Y, CEDERBAUM AI: Inactivation and degradation of human cytochrome P4502E1 by CCl4 in a transfected HepG2 cell line. J. Pharmacol. Exp. Ther. (1995) 275(3):1614–1622.
  • CHEN Q, GALLEANO M, CEDERBAUM AI: Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P4502E1. J. Biol. Chem. (1997) 272(23):14532–14541.
  • SAKURAI K, CEDERBAUM AI: Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol. Pharmacol. (1998) 54(6):1024–1035.
  • WU D, CEDERBAUM AI: Ethanol cytotoxicity to a transfected HepG2 cell line expressing human cytochrome P4502E1. J. Biol. Chem. (1996) 271(39):23914–23919.
  • WU D, CEDERBAUM AI: Removal of glutathione produces apoptosis and necrosis in HepG2 cells overexpressing CYP2E1. Alcohol. Clin. Exp. Res. (2001) 25(4):619–628.
  • CARO AA, CEDERBAUM AI: Synergistic toxicity of iron and arachidonic acid in HepG2 cells overexpressing CYP2E1. Mol. Pharmacol. (2001) 60(4):742–752.
  • WU D, CEDERBAUM AI: Ethanol and arachidonic acid produce toxicity in hepatocytes from pyrazole-treated rats with high levels of CYP2E1. Mol. Cell. Biochem. (2000) 204(1–2):157–167.
  • WU D, CEDERBAUM AI: Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes. Mol. Pharmacol. (2001) 59(4):795–805.
  • MARI M, CEDERBAUM AI: CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of γ-glutamylcysteine synthetase. J. Biol. Chem. (2000) 275(20):15563–15571.
  • NIETO N, MARI M, CEDERBAUM AI: Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit. Hepatology (2003) 37(1):96–106.
  • MARI M, CEDERBAUM AI: Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against shortterm oxidative stress. Hepatology (2001) 33(3):652–661.
  • SUSIN SA, ZAMZAMI N, KROEMER G: Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta (1998) 1366(1–2):151–165.
  • ORRENIUS S, ANKARCRONA M, NICOTERA P: Mechanisms of calciumrelated cell death. Adv. Neurol. (1996) 71:137–151.
  • TROST LC, LEMASTERS JJ: The mitochondrial permeability transition: a new pathophysiological mechanism for Reye’s syndrome and toxic liver injury. J. Pharmacol. Exp. Ther. (1996) 278(3):1000–1005.
  • MARI M, BAI J, CEDERBAUM AI: Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against toxicity caused by glutathione depletion in HepG2 cells expressing CYP2E1. J. Pharmacol. Exp. Ther. (2002) 301(1):111–118.
  • PEREZ MJ, CEDERBAUM AI: Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity. Free Radic. Biol. Med. (2001) 30(7):734–746.
  • BAI J, CEDERBAUM AI: Adenovirusmediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against cytochrome P450 2E1- dependent toxicity in HepG2 cells. J. Biol. Chem. (2001) 276(6):4315–4321.
  • WU D, CEDERBAUM AI: Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria. Hepatology (2002) 35(6):1420–1430.
  • GONG P, HU B, CEDERBAUM AI: Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch. Biochem. Biophys. (2004) 432(2):252–260.
  • CARO AA, CEDERBAUM AI: Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine. Biochem. Pharmacol. (2005) 69(7):1081–1093.
  • CHOI EY, KIM SG, LEE JW, YOO JK, SHIN JK, KIM ND: Suppression of rat hepatic cytochrome P450 2E1 expression by isopropyl 2-(1,3-dithioetane-2-ylidene)-2-[N-(4-methyl-thiazol-2-yl)carbamoyl] acetate (YH439), an experimental hepatoprotectant: protective role against hepatic injury. Biochem. Pharmacol. (1996) 52(8):1219–1225.
  • JEONG KS, LEE IJ, ROBERTS BJ et al. : Transcriptional inhibition of cytochrome P4502E1 by a synthetic compound, YH439. Arch. Biochem. Biophys. (1996) 326(1):137–144.
  • BARCELO S, GARDINER JM, GESCHER A, CHIPMAN JK: CYP2E1- mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis (1996) 17(2):277–282.
  • HE K, IYER KR, HAYES RN, SINZ MW, WOOLF TF, HOLLENBERG PF: Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res. Toxicol. (1998) 11(4):252–259.
  • MCCARTY MF: Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanol. Med. Hypotheses (2001) 56(1):8–11.
  • DONOHUE TM Jr, ZETTERMAN RK, ZHANG-GOUILLON ZQ, FRENCH SW: Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration. Hepatology (1998) 28(2):486–491.
  • HUAN JY, STREICHER JM, BLEYLE LA, KOOP DR: Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. Toxicol. Appl. Pharmacol. (2004) 199(3):332–343.
  • GOASDUFF T, CEDERBAUM AI: CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90. Arch. Biochem. Biophys. (2000) 379(2):321–330.
  • WEN F, ABDALLA MY, ALOMAN C et al. : Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells coexpressing HCV core protein and CYP2E1. J. Med. Virol. (2004) 72(2):230–240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.